Find Academic Supervisors

• Nanomedicine
• Molecular Imaging
• Nanotechnology
• +6 more

Dr. Roger Molto Pallares serves as a junior group leader (equivalent to Assistant Professor) at the Institute for Experimental Molecular Imaging (ExMI) within RWTH Aachen University's Faculty of Medicine, where he directs the "Biohybrid Nanomedical Materials" research group focused on developing bio-inspired nanomaterials for diagnostics and therapeutics since 2021. Education: PhD in Materials Science, University College London (UK), 2017 His research integrates nanomedicine , molecular imaging , and nanotechnology to engineer advanced diagnostic and therapeutic platforms. Key innovations include polymeric microbubbles with controlled microporosity for enhanced ultrasound imaging, gold nanostars for photoacoustic applications, and hybrid contrast agents combining metal phthalocyanines with microbubbles. His work addresses critical challenges in drug delivery precision, multimodal imaging sensitivity, and nanotoxicology assessment through omics approaches, with strong translational emphasis on cancer theranostics. Analysis of his 2020-2024 publications reveals a dominant trend toward multimodal theranostic platforms that merge ultrasound, photoacoustic, and molecular imaging techniques with engineered nanomaterials. The research consistently emphasizes structure-function optimization at the nanoscale—whether through microporosity engineering in microbubbles, surface modification of gold nanostars, or hybrid material design—to simultaneously enhance diagnostic capabilities and therapeutic efficacy while rigorously evaluating biocompatibility. Scientific Awards: Vulcanus in Japan fellowship RWTH JPI Fellowship Umbrella Award JNB Rising Star Award 2025 Dr. Pallares serves on the leadership committee of the Molecular Imaging in Nanotechnology and Theranostics (MINT) Interest Group within the World Molecular Imaging Society (WMIS). His research group operates with significant institutional support, evidenced by his junior group leader appointment and multiple competitive fellowships. Current projects include developing targeted alpha therapy platforms and advancing biohybrid nanomaterials for clinical translation. The "Biohybrid Nanomedical Materials" research group (established 2021) functions within ExMI's advanced imaging infrastructure at University Hospital Aachen. The team combines materials science, molecular biology, and imaging expertise to create next-generation nanoplatforms, with active collaborations spanning Lawrence Berkeley National Laboratory, Northwestern University, and international consortia focused on nanomedicine standardization and safety assessment.

John FortnerView profile

Professor

• Environmental Engineering
• Nanotechnology
• Water Treatment
• +4 more

John Fortner is a Professor of Chemical & Environmental Engineering at Yale University, affiliated with the School of Engineering & Applied Science. He leads the Fortner Lab, focusing on advanced nanomaterials for environmental remediation, particularly PFAS treatment, water purification, and energy sustainability. His research integrates material science, environmental engineering, and toxicology to address critical challenges in health and energy. **Education**: Ph.D., Rice University (Environmental Engineering); B.S., Texas A&M University (Chemical Engineering). He has held leadership roles in major conferences and societies, including Chair of the Environmental Nanotechnology Gordon Research Conference (2023) and membership in the Royal Society of Chemistry (Fellow, 2021). **Research Interests**: Development of novel materials (e.g., MOFs, graphene composites) for contaminant removal, PFAS exposure analysis in neonatal populations, and scalable nanomaterial synthesis. Recent work emphasizes microwave-enhanced catalysis, electrochemical remediation, and sustainable PFOA/PFOS treatment. **Awards & Honors**: Over 10 prestigious awards, including the NSF CAREER Award (2015), Walter L. Huber Civil Engineering Research Prize (2020), and election to the Connecticut Academy of Science and Engineering (2024). **Advising & Lab**: Supervises a diverse team of graduate and undergraduate students in projects like PFAS adsorption, metal-organic frameworks, and composite materials. Lab alumni include Dr. Junseok Lee (now at Incheon National University). **Lab Activities**: Hosts regular group dinners, symposiums (e.g., 2022 IICEE competition win), and collaborates with industry (e.g., Suez Water Technologies). The lab mascot is BEAR, symbolizing team cohesion.

• Antimicrobial Resistance
• Nanotechnology
• Theranostic Devices
• +5 more

Dr. Christopher O'Kane is a Lecturer at the Faculty of Science and Engineering , Anglia Ruskin University , specializing in Microbiology , Molecular Diagnostics , and Nanotechnology . His research focuses on Antimicrobial Resistance and Theranostic Devices , integrating Pharmaceutical Nanoscience and Cancer Biology . Education : PhD in DNA Nanotechnology (Ulster University, 2016), BSc (Hons) Biomedical Science (Ulster University, 2012), PG Cert in Learning and Teaching (Higher Education) (Anglia Ruskin University, 2017) His research explores non-canonical DNA structures for biomedical applications, antimicrobial gene regulation , and nanodevice development . Publications emphasize interdisciplinary approaches bridging microbiology , nanoscience , and diagnostics . Scientific awards include grants from the Wellcome Trust , IBMS Albert Norman Trust , and Biochemical Society , alongside teaching certifications and memberships in the Institute of Biomedical Science and Royal Society of Chemistry .

Sally PeymanView profile

Associate Professor

• Microfluidics
• Organ-on-chip Technology
• Drug Delivery Mechanisms
• +5 more

Sally Peyman is an Associate Professor at Heriot-Watt University's Institute of Biological Chemistry, Biophysics and Bioengineering, within the School of Engineering & Physical Sciences. She holds a Visiting Professor position at the University of Leeds (2024–2027). Her academic journey includes a BSc in Chemistry with Forensic Science & Toxicology from the University of Hull, a PhD in microfluidics for clinical diagnostics (2010, supervised by Prof. Nicole Pamme), and postdoctoral roles at Imperial College London and the University of Leeds. Her research focuses on microfluidics, organ-on-chip models, drug delivery mechanisms, tumour mechanics, and biosensors. Key contributions include developing lab-on-a-chip solutions for cancer biophysics and replacing animal models in research. Recent work addresses drug delivery barriers in pancreatic cancer, hydrogel mechanics, and ultrasound-triggered therapeutics. Notable collaborations involve interdisciplinary teams in nanotechnology, biomedical engineering, and environmental science. Sally’s work aligns with UN Sustainable Development Goals related to health and innovation. She actively supervises PhD students and contributes to academic leadership in her field.

• Clinical Sciences
• Cardiorespiratory Medicine and Haematology
• Biochemistry and Cell Biology
• +3 more

Graeme Birdsey is an Associate Professor in Vascular Science at the National Heart & Lung Institute, part of Imperial College London's Faculty of Medicine. His research focuses on transcriptional and epigenetic regulation of endothelial cell gene expression in angiogenesis and lymphangiogenesis. He has held affiliations with the CDT in Chemical Biology, the Institute of Chemical Biology, the Stem Cell Regenerative Medicine Network, and the Vascular Science Network. Dr. Birdsey earned a BSc in Applied Biochemistry from Liverpool John Moores University and a PhD in Molecular Cell Biology from University College London (UCL). His postdoctoral training included work in Prof. Chris Danpure's lab (UCL) on alanine:glyoxylate aminotransferase (AGT) targeting, followed by studies on nitric oxide regulation under Prof. Patrick Vallance at UCL. His research spans vascular biology, with emphasis on ERG transcription factor roles in endothelial cell function, vascular inflammation, and disease mechanisms. Key areas include lymphatic malformations, cardiovascular diseases, and genetic syndromes linked to ERG mutations. His work integrates molecular biology, genomics, and 3D modeling approaches. Publications highlight contributions to vascular biology, including ERG's role in angiogenesis regulation, therapeutic strategies using ultrasound-microbubble systems, and genetic insights into rare diseases. His research bridges basic science and clinical applications in cardiovascular and inflammatory disorders.

Simona TurcoView profile

Assistant Professor

• Medical Imaging
• Biomedical Signal Processing
• Angiogenesis
• +4 more

Simona Turco is an Assistant Professor at the Electrical Engineering department at Eindhoven University of Technology. She is affiliated with the Biomedical Diagnostics (BM/d) Lab and the Eindhoven MedTech Innovation Center (e/MTIC). Her research focuses on model-driven analysis of medical images and biosignals for oncology and perioperative care. MSc Biomedical Engineering, University of Pisa (2012) Professional Doctorate in Engineering (PDEng), TU/e (2015) PhD, TU/e (2018) Her research integrates pharmacokinetic modeling and machine learning to advance diagnostics in cancer (angiogenesis imaging) and perioperative risk prediction. She utilizes contrast-enhanced ultrasound and MRI for multi-scale functional and molecular analysis. Key subfields include microbubble dynamics, dispersion imaging, and biosignal modeling. Recent publications highlight applications in prostate cancer radiogenomics, renal cell carcinoma, adenomyosis, and patient-ventilator asynchrony. She combines mathematical modeling with data-driven approaches for clinical translation, supported by collaborations with healthcare partners. Scientific Awards: Academy Van Leersum Grant (2019) Best Paper (3rd place), IEEE-EMBS (2017) Best Poster Awards at European Symposium on Ultrasound Contrast Imaging (2019) and IEEE-EMBS Benelux (2017) Hanart Fonds Fellowship (2019) She contributes to projects like MEDICAID (cardiovascular diagnostics) and PISANO SPS (perioperative innovation), with over 86 research outputs and 5 datasets. Her work aligns with the UN Sustainable Development Goals for healthcare innovation.

Brandon HelfieldView profile

Assistant Professor

• Biomedical Ultrasound Imaging
• Focused Ultrasound Therapy
• Molecular Biophysics
• +5 more

Brandon Helfield is an Assistant Professor at Concordia University with cross-appointments in Physics and Biology. He holds the Tier II Canada Research Chair in Molecular Biophysics in Human Health and serves as a Junior Scientist at the Physical Sciences Platform of Sunnybrook Research Institute. His research bridges biomedical ultrasound, microbubble dynamics, and therapeutic applications. Education : PhD in Medical Biophysics (University of Toronto), BSc in Physics (McGill University), Postdoctoral Fellowship in Cardiology (University of Pittsburgh) Research Interests : Dr. Helfield focuses on biomedical ultrasound imaging and therapy, particularly microbubble-based technologies for targeted drug/gene delivery to treat cardiovascular diseases. His recent work explores CRISPR-Cas9 delivery to stem cells, immunomodulation via focused ultrasound, and super-resolution imaging algorithms. Publication Trends : His research spans ultrasound physics, microbubble dynamics, and clinical translation. Key areas include cavitation mechanics, vascular delivery optimization, and machine learning applications for imaging analysis. Awards : Burroughs Wellcome Fund Career at the Scientific Interface Award, Arthur E. Weyman Young Investigator Award, European Symposium on Ultrasound Young Investigator Award

Ankit RochaniView profile

Visiting Assistant Professor

• Pharmaceutical Sciences
• Nanoformulation Development
• Drug Delivery Systems
• +5 more

Ankit Rochani is a Visiting Assistant Professor at St. John Fisher University's Department of Pharmacy/Pharmaceutical Sciences. He holds a Ph.D. from Toyo University, Japan, with postdoctoral fellowships at Toyo University and Thomas Jefferson University in Philadelphia. His research focuses on developing semisolid and nanoformulations using sustainable green biomaterials, particularly in cancer therapy and maternal-fetal pharmacology. He specializes in HPLC and LC-MS/MS method development for drug stability analysis and has contributed to studies on aspirin pharmacokinetics in pregnancy and targeted drug delivery via ultrasound-sensitive oxygen microbubbles. His work supports clinical pharmacies and compounding facilities through stability data generation. Dr. Rochani has received significant awards, including the Japanese Government Scholarship (MEXT) and grants from St. John Fisher University (SIG, FIDG, FRAP). His publications span 2010 to 2025, addressing drug formulation, nanomedicine, and clinical trials. He collaborates with prominent researchers like Gagan Kaushal and Walter Kraft on projects ranging from cancer nanotherapy to obstetric drug safety. Additionally, he integrates innovative lab-based compounding courses into online PharmD programs, emphasizing practical skills for future pharmacists. His research interests also include theranostics in nanomedicine and biomaterials for tissue engineering. He has presented at conferences such as AAPS-Northeast Regional Discussion Group, where he received a Short Topic Presentation Award, and contributed to book chapters on nanomedicine and cancer therapy. His interdisciplinary work bridges pharmacy, materials science, and clinical practice, aiming to enhance personalized drug delivery and patient outcomes.

Emad EbbiniView profile

Professor

• Ultrasound Imaging
• Signal Processing
• Noninvasive Surgery
• +7 more

Emad Ebbini is a Professor in the Department of Electrical and Computer Engineering at the University of Minnesota. He leads the Ultrasound Imaging & Signal Processing Lab , focusing on developing image-guided ultrasound phased-array systems for noninvasive surgery and neuromodulation. His work integrates real-time 3D imaging, temperature mapping, and self-focusing arrays for therapeutic applications. Research Focus: High-Intensity Focused Ultrasound (HIFU), Transcranial Ultrasound, Neuromodulation, Vascular Imaging, Nonlinear Ultrasound Current Projects: First-in-human HIFU trials for cancer immunotherapy, wearable tFUS systems, and awake animal neuromodulation studies funded by NIH and Rainwater Charitable Foundation Scientific Contributions: Pioneered dual-mode ultrasound arrays, transskull refocusing techniques, and Volterra filter-based nonlinear imaging. His lab advances HIFU for atherosclerosis, pancreatic cancer, and neurovascular ablation. Collaborations: Works with researchers in neurology, radiology, and biomedical engineering, emphasizing SDGs related to health innovation. His publications span therapeutic ultrasound, signal processing, and medical device design.

• Ultrasound Theranostics
• Stimuli-Responsive Materials
• Drug Delivery Systems
• +7 more

Caroline De Gracia Lux is a researcher in the Department of Radiology at UT Southwestern Medical Center, where she contributes to the Translational Research in Ultrasound Theranostics (TRUST) program. Her work bridges synthetic chemistry and biomedical imaging, focusing on the development of advanced ultrasound contrast agents and stimuli-responsive materials for cancer theranostics. Education: Ph.D. in Chemistry, University of Strasbourg, under the mentorship of Dr. Marie-Pierre Krafft Postdoctoral Training, University of California, San Diego (UCSD) Micro-MBA, Rady School of Management, UCSD (focusing on leadership, strategy, finance, and communication) Her research interests lie at the intersection of synthetic chemistry , nanomaterials , and medical imaging . She specializes in designing activatable ultrasound contrast agents, particularly using superheated perfluorocarbon nanodroplets that undergo acoustic vaporization. These agents are engineered to respond to biological triggers such as oxidative stress or abnormal pH, enabling targeted imaging and therapy in cancer and inflammatory conditions. Her work also includes the development of biocompatible, degradable polymers for controlled drug release. The most recent publications highlight a strong trend toward translational applications of nanomaterials in ultrasound imaging and theranostics . Keywords across her work include stimuli-responsiveness, macrophage targeting, phase-change agents, and multimodal imaging. Subfields span pH-sensitive microbubbles, oxidative microenvironment sensing, nanoparticle formulation, and imaging phantom development, reflecting a highly interdisciplinary and clinically oriented research program. Scientific Awards: No awards listed in the provided text. While no formal advising role is explicitly stated, Dr. de Gracia Lux collaborates extensively on multidisciplinary projects involving grants in nanomedicine, imaging, and drug delivery. Her work is supported by institutional programs such as TRUST at UT Southwestern. She has contributed to research funded by NIH and other biomedical research agencies, though specific grants are not mentioned. She is affiliated with the de Gracia Lux Lab , which focuses on ultrasound theranostics and responsive materials. The lab develops novel contrast agents, investigates macrophage imaging, and creates phantoms for validating quantitative imaging techniques. The team employs expertise in synthetic chemistry, formulation science, and preclinical imaging to advance cancer diagnostics and therapy.

• Biomedical Engineering
• Ultrasound Therapy
• Drug Delivery
• +3 more

Petros Tesfamichael Yemane serves as a Postdoctoral Fellow (Research Fellow) in the Department of Physics at the Norwegian University of Science and Technology (NTNU), where he conducts cutting-edge research at the intersection of medical physics and biomedical engineering. His work focuses on leveraging ultrasound technology to enhance targeted drug delivery systems for cancer treatment. His research expertise spans: Biomedical Engineering Ultrasound Therapy Drug Delivery Mechanisms Nanomedicine Applications Cancer Treatment Optimization Medical Physics Instrumentation Analysis of Dr. Yemane's publication record reveals a consistent trajectory in ultrasound-mediated drug delivery research, with emphasis on real-time visualization of nanoparticle behavior in tumor environments. His work demonstrates how acoustic radiation force and sonication techniques can manipulate nanoparticle distribution in collagen matrices and solid tumors, directly addressing challenges in tumor penetration and drug bioavailability. Key methodologies include multiphoton microscopy for live imaging and computational modeling of radiation force effects, contributing significantly to the development of microbubble-enhanced delivery platforms. He actively disseminates findings through international conferences including the European Symposium on Ultrasound Contrast Imaging and the Oncological Drug Delivery Conference, collaborating with institutions across Europe to advance nanomedicine applications in oncology.

• Biotechnology
• Nanotechnology
• Microfluidics
• +5 more

Esra İLHAN AYIŞIĞI is a Lecturer in the Department of Genetics and Bioengineering at the Faculty of Engineering and Architecture, Kirsehir Ahi Evran University, where she has served since 2024 after working as a Research Assistant from 2021-2024. She previously held research positions at Ege University from 2014-2021. Her academic credentials include: PhD in Bioengineering from Ege University (2015-2021) Master's Degree in Bioengineering from Ege University (2012-2015) Bachelor's Degree in Bioengineering from Ege University (2007-2012) Dr. İLHAN AYIŞIĞI's research spans biotechnology, nanotechnology, and microfluidics , with particular emphasis on drug delivery systems, tissue engineering, and cancer therapeutics. Her work bridges engineering principles with biological applications, developing innovative solutions for medical challenges through microfluidic platforms and nanomaterial design. Analysis of her publication record reveals a strong focus on nanoparticle-based drug delivery and 3D bioprinting for tissue regeneration , with increasing emphasis on targeted cancer therapies and biomimetic scaffolds. Her research trajectory demonstrates progression from fundamental nanomaterial synthesis to increasingly complex translational applications in bone regeneration, cartilage repair, and cancer treatment. Her scientific recognition includes: Biodesign for Aesthetics - Best Poster Award (2015, Ege University) Dr. İLHAN AYIŞIĞI actively leads and participates in numerous research projects, including as principal investigator for "Synthesis of Carvacrol-Loaded Nanoformulations on Microfluidic Platform" and "Elisitor Effects on β-carotene Production in Daucus carota L. Suspension Cultures." She maintains extensive collaborations with researchers across Turkey and internationally, particularly in nanomedicine and tissue engineering fields. Her laboratory work centers on microfluidic platforms for nanoparticle synthesis and characterization, combining expertise in biomaterials science, microfluidics, and molecular biology to develop innovative therapeutic solutions with clinical translation potential.

• Neuroscience
• Neurology
• Neurosurgery
• +5 more

Abbas Sadikot, MD, PhD, is a Professor in the Department of Neurology and Neurosurgery at McGill University's Faculty of Medicine and Health Sciences. He serves as an Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC) and the Montreal Neurological Institute and Hospital, where he is a member of the Brain Repair and Integrative Neuroscience (BRaIN) Program. Clinically, he is affiliated with the Department of Neurosciences, Division of Neurosurgery, at the MUHC. Dr. Sadikot holds an MD and PhD; specific educational details are unavailable in the provided text. His research focuses on deep brain stimulation for movement disorders, neurodegenerative diseases (particularly Parkinson's disease), and advanced neuroimaging techniques . He pioneers ultrasound localization microscopy for brain vasculature imaging and investigates neural mechanisms underlying tremor and Parkinson's pathology. His work bridges surgical innovation with fundamental neuroscience. Recent publications (2021-2025) emphasize ultrasound-based vascular imaging techniques that achieve high resolution without ECG gating, alongside blood-brain barrier modulation for therapy planning. His studies also address deep brain stimulation targeting accuracy and quantitative tremor characterization using accelerometry. Dr. Sadikot collaborates within the BRaIN Program and leverages RI-MUHC technology platforms including Medical Imaging and the Experimental Operating Room for translational neurosurgical applications.

• Biomedical Engineering
• Biomaterials
• Artificial Blood Substitutes
• +4 more

Shinji Takeoka is a Professor at Waseda University's Faculty of Science and Engineering and School of Advanced Science and Engineering, with over 30 years of academic leadership in biomedical engineering and biomaterials. His research focuses on artificial blood substitutes , liposome-based drug delivery , and nanosheet biomedical devices , achieving 359 publications and h-index 64 (Google Scholar). Key Research Areas: Artificial platelet formulations (H12-(ADP)-liposomes) Nanosheet scaffolds for stem cell spheroids Flexible biomedical sensors and implantable devices Scientific Achievements: Okuma Memorial Academic Award (2011) Developed oxygen measurement methods for fine bubble dispersions Engineered microreactors and temperature-responsive immunosorbent assays His work bridges biomaterials science and clinical hemostasis , with significant translational potential for trauma care and regenerative medicine.

• Dendrimer Chemistry
• Nanomedicine
• Cancer Diagnosis and Therapy
• +4 more

Xiangyang Shi is a Professor at Donghua University's College of Chemistry, Chemical Engineering and Biotechnology and holds an Invited Chair in Nanotechnology at the University of Madeira. His primary academic affiliations demonstrate strong international collaboration between Chinese and Portuguese research institutions, with significant contributions to nanomedicine and materials science. His research focuses on dendrimer chemistry and nanomedicinal applications , particularly in cancer diagnosis and therapy. Additional research areas include nanofiber-based technology for bioscaffolding materials in tissue engineering, pharmaceutical applications, and environmental nanotechnology through immobilization of reactive nanoparticles. His work bridges chemistry, materials science, and biomedical engineering with strong translational potential. Analysis of his recent publications (2025) reveals a strong emphasis on combination cancer therapies integrating chemotherapy, immunotherapy, and imaging modalities. Key trends include development of metal-phenolic networks , stimuli-responsive nanogels , and dual-targeting nanovaccines for enhanced tumor treatment. His work increasingly focuses on disrupting tumor microenvironment mechanisms like hypoxia and adenosine pathways while enhancing immune checkpoint blockade. His research has been supported by significant grants including: DENDIMAGE - Development of Novel Dendrimer-Based Nanoparticles for Dual Mode Computed Tomography and Magnetic Resonance Imaging of Tumors (2013-2015) Self-assembled nanoparticles based on PEG-PLA-dendrimer building blocks for dual gene/drug delivery (2012-2015) These projects were funded by Fundação para a Ciência e a Tecnologia (Portugal). Professor Shi leads research activities centered around dendrimer-based nanoplatforms with strong international collaboration networks. His laboratory focuses on translating fundamental nanomaterial discoveries into therapeutic applications, particularly for cancer treatment and tissue engineering solutions. Current work emphasizes multimodal therapeutic approaches that combine imaging capabilities with targeted treatment modalities.